Caroline Michaela Nervil Kistorp

Caroline Michaela Nervil Kistorp

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. Published

    Metabolic Effects of Empagliflozin in Heart Failure A Randomized, Double-Blind, and Placebo-Controlled Trial (Empire HF Metabolic)

    Jensen, J., Omar, M., Kistorp, Caroline Michaela Nervil, Tuxen, C., Gustafsson, I., Køber, Lars Valeur, Gustafsson, Finn, Faber, Jens, Forman, Julie Lyng, Møller, J. E. & Schou, Morten, 2021, In: Circulation. 143, 22, p. 2208-2210 3 p.

    Research output: Contribution to journalLetterResearchpeer-review

  2. Published

    Twelve weeks of treatment with empagliflozin in patients with heart failure and reduced ejection fraction: A double-blinded, randomized, and placebo-controlled trial

    Jensen, J., Omar, M., Kistorp, Caroline Michaela Nervil, Poulsen, M. K., Tuxen, C., Gustafsson, I., Køber, Lars Valeur, Gustafsson, Finn, Faber, Jens, Fosbøl, E. L., Bruun, Niels Eske, Brønd, J. C., Forman, Julie Lyng, Videbæk, L., Møller, J. E. & Schou, Morten, 2020, In: American Heart Journal. 228, p. 47-56 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Low N-terminal pro-brain natriuretic peptide levels are associated with non-alcoholic fatty liver disease in patients with type 2 diabetes

    Johansen, M. L., Schou, Morten, Rasmussen, J., Rossignol, P., Holm, M. R., Chabanova, E., Dela, Flemming, Faber, Jens & Kistorp, Caroline Michaela Nervil, 2019, In: Diabetes & Metabolism. 45, 5, p. 429-435

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Published

    Effect of the mineralocorticoid receptor antagonist eplerenone on liver fat and metabolism in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled trial (MIRAD trial)

    Johansen, M. L., Schou, Morten, Rossignol, P., Holm, M. R., Rasmussen, J., Brandt, N., Frandsen, M., Chabanova, E., Dela, Flemming, Faber, Jens & Kistorp, Caroline Michaela Nervil, 2019, In: Diabetes, Obesity and Metabolism. 21, 10, p. 2305-2314 10 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    The Mineralocorticoid Receptor Antagonist Eplerenone Suppresses Interstitial Fibrosis in Subcutaneous Adipose Tissue in Patients With Type 2 Diabetes

    Johansen, M. L., Ibarrola, J., Fernández-Celis, A., Schou, Morten, Sonne, M. P., Refsgaard Holm, M., Rasmussen, J., Dela, Flemming, Jaisser, F., Faber, Jens, Rossignol, P., Lopez-Andres, N. & Kistorp, Caroline Michaela Nervil, 2021, In: Diabetes. 70, 1, p. 196-203 8 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  6. Published

    Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)-a multicentre, double-blind, randomised, placebo-controlled trial

    Jorsal, A., Kistorp, Caroline Michaela Nervil, Holmager, P., Tougaard, R. S., Nielsen, R. R., Hänselmann, A., Nilsson, B., Møller, J. E., Hjort, J., Rasmussen, J., Boesgaard, T. W., Schou, Morten, Videbæk, L., Gustafsson, I., Flyvbjerg, A., Wiggers, H. & Tarnow, L., Jan 2017, In: European Journal of Heart Failure. 19, 1, p. 69-77 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    A protocol for a randomised, double-blind, placebo-controlled study of the effect of LIraglutide on left VEntricular function in chronic heart failure patients with and without type 2 diabetes (The LIVE Study)

    Jorsal, A., Wiggers, H., Holmager, P., Nilsson, B., Nielsen, R., Boesgaard, T. W., Kumme, A., Møller, J. E., Videbæk, L., Kistorp, Caroline Michaela Nervil, Gustafsson, I., Tarnow, L. & Flyvbjerg, A., 2014, In: B M J Open. 4, 5, p. 1-7 7 p., e004885.

    Research output: Contribution to journalJournal articleResearchpeer-review

  8. Published

    Effects of empagliflozin on myocardial flow reserve in patients with type 2 diabetes mellitus: The simple trial

    Jürgens, M., Schou, Morten, Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Wiberg, M., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn & Kistorp, Caroline Michaela Nervil, 2021, In: Journal of the American Heart Association. 10, 15, e020418.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Design of a randomised controlled trial of the effects of empagliflozin on myocardial perfusion, function and metabolism in type 2 diabetes patients at high cardiovascular risk (the SIMPLE trial)

    Jürgens, M., Schou, Morten, Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Wiberg, M., Brandt, N. H., Gæde, P. H., Rossing, Peter, Faber, Jens, Inzucchi, S., Gustafsson, Finn & Kistorp, Caroline Michaela Nervil, 2019, In: BMJ Open. 9, 11, 8 p., e029098.

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    The effects of empagliflozin on measured glomerular filtration rate and estimated extracellular and plasma volumes in patients with type 2 diabetes

    Jürgens, M., Schou, Morten, Hasbak, P., Kjær, Andreas, Wolsk, E., Zerahn, B., Brandt-Jacobsen, N. H., Gæde, P., Rossing, Peter, Faber, Jens, Inzucchi, S. E., Gustafsson, Finn & Kistorp, Caroline Michaela Nervil, 2023, In: Diabetes, Obesity and Metabolism. 25, 10, p. 2888-2896 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

Previous 1 2 3 4 5 6 7 8 ...10 Next

ID: 33970309